Skip to main content
. 2013 Jun 4;22(20):4127–4135. doi: 10.1093/hmg/ddt261

Table 1.

Twelve miRNAs are altered in end-stage ALS mouse and rat spinal cords by microarray

  Mouse
Rat
RQ: SOD1G93A/non-TG T-test RQ: SOD1G93A/non-TG T-test RQ: SOD1G93A/SOD1WT T-test
miR-17 2.66 0.00 1.99 0.04 11.58 0.00
miR-19b 2.51 0.00 1.99 0.10 9.20 0.02
miR-20a 2.33 0.01 1.79 0.10 20.60 0.01
miR-24-2-5p 2.44 0.02 1.78 0.06 3.22 0.00
miR-106a 2.59 0.01 2.11 0.01 11.14 0.00
miR-142-3p 3.36 0.04 3.81 0.06 24.84 0.02
miR-142-5p 3.27 0.05 10.61 0.17 2.94 0.34
miR-146a 8.86 0.00 3.89 0.02 8.79 0.01
miR-146b 3.02 0.01 1.84 0.04 2.95 0.01
miR-155 2.08 0.01 20.08 0.20 58.75 0.19
miR-223 3.52 0.05 1.89 0.14 10.25 0.02
miR-338-3p 2.27 0.01 1.75 0.16 5.33 0.03

miRNAs were isolated from end-stage SOD1G93A mouse and rat spinal cords and from age-matched non-transgenic (non-TG) controls (n = 3–4). For rats, miRNAs were also isolated from age-matched SOD1WT control spinal cords (n = 3). A total of 673 miRNAs were assayed using Applied Biosystem's TaqMan Rodent Array A + B Cards v3.0 and 434 miRNAs amplified and were quantified. For mice, 6 miRNAs were decreased and 37 miRNAs were increased greater than 2-fold at P < 0.05. From these 43 miRNAs, 12 were also changed >50% in the rat samples at P < 0.20. RQ, relative quantification.